Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

被引：0
|
作者：
Bumma, Naresh [1 ]
Reu, Frederic J. [1 ]
Samaras, Christy [1 ]
Duong, Hien K. [1 ]
Smith, Mitchell R. [1 ]
Valent, Jason [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
    Reece, Donna E.
    Sanchorawala, Vaishali
    Hegenbart, Ute
    Merlini, Giampaolo
    Palladini, Giovanni
    Fermand, Jean-Paul
    Vescio, Robert A.
    Liu, Xiangyang
    Elsayed, Yusri A.
    Cakana, Andrew
    Comenzo, Raymond L.
    BLOOD, 2009, 114 (08) : 1489 - 1497
  • [42] Safety of delivery of bortezomib to patients with cardiac AL Amyloidosis: The impact of cardiac monitoring
    Attwood, C.
    Sado, D.
    Rice, C.
    Streetly, M.
    El-Najjar, I.
    Wechalekar, A.
    Gunning, D.
    Deppe, S.
    Benjamin, R.
    Cuthill, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 97 - 98
  • [43] Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
    Guja, Cristian
    Frias, Juan P.
    Suchower, Lisa
    Hardy, Elise
    Marr, Galina
    Sjostrom, C. David
    Jabbour, Serge A.
    DIABETES THERAPY, 2020, 11 (07) : 1467 - 1480
  • [44] Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
    Cristian Guja
    Juan P. Frías
    Lisa Suchower
    Elise Hardy
    Galina Marr
    C. David Sjöström
    Serge A. Jabbour
    Diabetes Therapy, 2020, 11 : 1467 - 1480
  • [45] EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS INJECTION OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Fu, C.
    Liu, H.
    Wu, D.
    Xue, S.
    Li, W.
    Wu, Q.
    Gu, B.
    Jin, S.
    Zhu, X.
    Zhao, S.
    Xin, X.
    Ma, L.
    Sun, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452
  • [46] Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
    Tan, Xueying
    Cao, Xiaojing
    Zhou, Minzhi
    Zou, Ping
    Hu, Jingbo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (09) : 1083 - 1089
  • [47] Efficacy and Safety by Duration of Diabetes with Once-Weekly Dulaglutide in the AWARD Program
    Gallwitz, Baptist
    Pavo, Imre
    Thieu, Vivian
    Jia, Nan
    Zhang, Nan
    Garcia-Perez, Luis-Emilio
    DIABETES, 2016, 65 : A269 - A269
  • [48] Differences in Safety and Efficacy of Generic and Original Branded once weekly Bisphosphonates.
    Ringe, J. D.
    Farahmand, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S463 - S463
  • [49] Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
    Jayakumari, Chellama
    Nair, Abilash
    Khadar, Jabbar Puthiyaveettil
    Das, Darvin, V
    Prasad, Nandini
    Jessy, S. J.
    Gopi, Anjana
    Guruprasad, Padmanabhan
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (12) : 2184 - 2193
  • [50] EFFICACY AND SAFETY OF WEEKLY INFUSION BORTEZOMIB IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Bringhen, S.
    Genuardi, M.
    Rossi, D.
    Petrucci, M.
    Andriani, A.
    Rizzi, R.
    Mele, G.
    Aitoro, G.
    Mettivier, V.
    Annibali, O.
    Rossini, F.
    Gentilini, P.
    Pavone, V.
    Cellini, C.
    Giuliani, N.
    Rauco, A.
    Baraldi, A.
    Dominietto, A.
    Capaldi, A.
    Pescosta, N.
    Rizzi, R.
    Nozza, A.
    Spadano, A.
    De Stefano, V.
    Holanek, M.
    Gaidano, G.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 149 - 149
12345